Your browser doesn't support javascript.
loading
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology.
Went, Molly; Sud, Amit; Speedy, Helen; Sunter, Nicola J; Försti, Asta; Law, Philip J; Johnson, David C; Mirabella, Fabio; Holroyd, Amy; Li, Ni; Orlando, Giulia; Weinhold, Niels; van Duin, Mark; Chen, Bowang; Mitchell, Jonathan S; Mansouri, Larry; Juliusson, Gunnar; Smedby, Karin E; Jayne, Sandrine; Majid, Aneela; Dearden, Claire; Allsup, David J; Bailey, James R; Pratt, Guy; Pepper, Chris; Fegan, Chris; Rosenquist, Richard; Kuiper, Rowan; Stephens, Owen W; Bertsch, Uta; Broderick, Peter; Einsele, Hermann; Gregory, Walter M; Hillengass, Jens; Hoffmann, Per; Jackson, Graham H; Jöckel, Karl-Heinz; Nickel, Jolanta; Nöthen, Markus M; da Silva Filho, Miguel Inacio; Thomsen, Hauke; Walker, Brian A; Broyl, Annemiek; Davies, Faith E; Hansson, Markus; Goldschmidt, Hartmut; Dyer, Martin J S; Kaiser, Martin; Sonneveld, Pieter; Morgan, Gareth J.
Afiliação
  • Went M; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK. molly.went@icr.ac.uk.
  • Sud A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Speedy H; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Sunter NJ; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.
  • Försti A; German Cancer Research Center, 69120, Heidelberg, Germany.
  • Law PJ; Center for Primary Health Care Research, Lund University, SE-205 02, Malmo, Sweden.
  • Johnson DC; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Mirabella F; Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Holroyd A; Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Li N; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Orlando G; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Weinhold N; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • van Duin M; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
  • Chen B; Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.
  • Mitchell JS; Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.
  • Mansouri L; German Cancer Research Center, 69120, Heidelberg, Germany.
  • Juliusson G; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Smedby KE; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 75105, Uppsala, Sweden.
  • Jayne S; Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Hematology and Transplantation, Lund University, Lund, Sweden.
  • Majid A; Unit of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Dearden C; Ernest and Helen Scott Haematological Research Institute, Leicester University, Leicester, UK.
  • Allsup DJ; Ernest and Helen Scott Haematological Research Institute, Leicester University, Leicester, UK.
  • Bailey JR; Division of Molecular Pathology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Pratt G; Department of Haematology, Hull Royal Infirmary, Hull, UK.
  • Pepper C; Hull York Medical School and University of Hull, Hull, UK.
  • Fegan C; Department of Haematology, Birmingham Heartlands Hospital, Birmingham, UK.
  • Rosenquist R; Department of Haematology, School of Medicine, Cardiff University, Cardiff, UK.
  • Kuiper R; Cardiff and Vale National Health Service Trust, Heath Park, Cardiff, UK.
  • Stephens OW; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 75105, Uppsala, Sweden.
  • Bertsch U; Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.
  • Broderick P; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
  • Einsele H; German Cancer Research Center, 69120, Heidelberg, Germany.
  • Gregory WM; National Centre of Tumor Diseases, 69120, Heidelberg, Germany.
  • Hillengass J; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, SW7 3RP, UK.
  • Hoffmann P; University Clinic of Würzburg, 97080, Würzburg, Germany.
  • Jackson GH; Clinical Trials Research Unit, University of Leeds, Leeds, LS2 9PH, UK.
  • Jöckel KH; Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.
  • Nickel J; Institute of Human Genetics, University of Bonn, D-53127, Bonn, Germany.
  • Nöthen MM; Division of Medical Genetics, Department of Biomedicine, University of Basel, 4003, Basel, Switzerland.
  • da Silva Filho MI; Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK.
  • Thomsen H; Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Walker BA; Department of Internal Medicine V, University of Heidelberg, 69117, Heidelberg, Germany.
  • Broyl A; Institute of Human Genetics, University of Bonn, D-53127, Bonn, Germany.
  • Davies FE; Department of Genomics, Life and Brain Center, University of Bonn, D-53127, Bonn, Germany.
  • Hansson M; German Cancer Research Center, 69120, Heidelberg, Germany.
  • Goldschmidt H; German Cancer Research Center, 69120, Heidelberg, Germany.
  • Dyer MJS; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
  • Kaiser M; Department of Hematology, Erasmus MC Cancer Institute, 3075 EA, Rotterdam, The Netherlands.
  • Sonneveld P; Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.
  • Morgan GJ; Center for Primary Health Care Research, Lund University, SE-205 02, Malmo, Sweden.
Blood Cancer J ; 9(1): 1, 2018 12 21.
Article em En | MEDLINE | ID: mdl-30602759
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Predisposição Genética para Doença / Estudos de Associação Genética / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Predisposição Genética para Doença / Estudos de Associação Genética / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article